SHARE BASED PAYMENTS (Tables)
|
12 Months Ended |
Mar. 31, 2025 |
Share-Based Payment Arrangement [Abstract] |
|
SCHEDULE OF OPTIONS TO PURCHASE SUBORDINATE VOTING SHARES |
Options
to purchase Subordinate Voting Shares have been granted to directors, employees, and consultants as follows:
SCHEDULE OF OPTIONS TO PURCHASE SUBORDINATE VOTING SHARES
Expiry date | |
Weighted Average Remaining Contractual Life in Years | | |
Exercise Price (CAD$) | | |
Exercise Price (USD$ equivalent) (1) | | |
Outstanding | |
June 16, 2027 | |
| 2.21 | | |
| 21.60 | | |
| 15.02 | | |
| 103,703 | |
September 16, 2027 | |
| 2.46 | | |
| 27.00 | | |
| 18.78 | | |
| 19,072 | |
April 28, 2028 | |
| 3.08 | | |
| 44.55 | | |
| 30.99 | | |
| 3,703 | |
December 15, 2028 | |
| 3.71 | | |
| 32.91 | | |
| 22.89 | | |
| 352,615 | |
December 23, 2028 | |
| 3.73 | | |
| 30.51 | | |
| 21.22 | | |
| 136,290 | |
April 15, 2029 | |
| 4.04 | | |
| 30.78 | | |
| 21.41 | | |
| 9,071 | |
July 3, 2029 | |
| 4.26 | | |
| 29.01 | | |
| 20.18 | | |
| 146,430 | |
| |
| 3.59 | | |
| 30.09 | | |
| 20.93 | | |
| 770,884 | |
| (1) | Converted
at balance sheet rate. |
|
SUMMARY OF STOCK OPTIONS |
A
summary of the Company’s stock options as at March 31, 2025, and changes for the years then ended is as follows:
SUMMARY OF STOCK OPTIONS
| |
Number
of stock options | | |
Weighted
Average Exercise Price (CAD$) | | |
Weighted
Average Exercise
Price (USD$
equivalent) (1) | |
Outstanding,
March 31, 2023 | |
| 258,516 | | |
| 21.68 | | |
| 15.08 | |
Granted | |
| 370,365 | | |
| 36.53 | | |
| 25.41 | |
Exercised | |
| (86,547 | ) | |
| 19.94 | | |
| 13.87 | |
Outstanding,
March 31, 2024 | |
| 542,334 | | |
$ | 32.09 | | |
$ | 22.32 | |
Granted | |
| 364,099 | | |
| 27.39 | | |
| 19.05 | |
Exercised | |
| (51,235 | ) | |
| 23.22 | | |
| 16.15 | |
Cancelled | |
| (84,314 | ) | |
| 35.37 | | |
| 24.60 | |
Outstanding,
March 31, 2025 | |
| 770,884 | | |
| 30.10 | | |
| 20.94 | |
Exercisable,
March 31, 2025 | |
| 511,487 | | |
$ | 29.92 | | |
$ | 20.81 | |
| (1) | Converted
at balance sheet rate. |
|
SCHEDULE OF THE BLACK-SCHOLES OPTION PRICING MODEL WITH THE FOLLOWING WEIGHTED AVERAGE ASSUMPTIONS |
SCHEDULE OF THE BLACK-SCHOLES OPTION PRICING MODEL WITH THE FOLLOWING WEIGHTED AVERAGE ASSUMPTIONS
| |
CAD$ | | |
$ | |
Share price at grant date | |
$ | 30.51 | | |
$ | 21.20 | |
Risk-free interest rate | |
| 3.04 | % | |
| 3.04 | % |
Expected life | |
| 5
years | | |
| 5
years | |
Expected volatility | |
| 100 | % | |
| 100 | % |
Expected forfeitures | |
| 0 | % | |
| 0 | % |
Expected dividends | |
| Nil | | |
| Nil | |
Grant date fair value per option | |
$ | 23.06 | | |
$ | 16.02 | |
| |
CAD$ | | |
$ | |
Share price at revaluation date | |
$ | 23.25 | | |
$ | 16.16 | |
Risk-free interest rate | |
| 2.61 | % | |
| 2.61 | % |
Expected life | |
| 5
years | | |
| 5
years | |
Expected volatility | |
| 121.6 | % | |
| 122 | % |
Expected forfeitures | |
| 0 | % | |
| 0 | % |
Expected dividends | |
| Nil | | |
| Nil | |
Revaluation date fair value per option | |
$ | 18.91 | | |
$ | 13.14 | |
| |
CAD$ | | |
$ | |
Share price at grant date | |
$ | 14.31 | | |
$ | 10.45 | |
Risk-free interest rate | |
| 3.07 | % | |
| 3.07 | % |
Expected life | |
| 4.2
years | | |
| 4.2
years | |
Expected volatility | |
| 100.0 | % | |
| 100 | % |
Expected forfeitures | |
| 0 | % | |
| 0 | % |
Expected dividends | |
| Nil | | |
| Nil | |
Grant date fair value per option | |
$ | 10.20 | | |
$ | 7.45 | |
| |
CAD$ | | |
$ | |
Share price at grant date | |
$ | 28.89 | | |
$ | 21.19 | |
Risk-free interest rate | |
| 3.57 | % | |
| 3.57 | % |
Expected life | |
| 5
years | | |
| 5
years | |
Expected volatility | |
| 100.0 | % | |
| 100 | % |
Expected forfeitures | |
| 0 | % | |
| 0 | % |
Expected dividends | |
| Nil | | |
| Nil | |
Weighted average grant date fair value per option | |
$ | 21.87 | | |
$ | 16.04 | |
| |
CAD$ | | |
$ | |
Share price at revaluation date | |
$ | 23.25 | | |
$ | 16.17 | |
Risk-free interest rate | |
| 2.47 | % | |
| 2.47 | % |
Expected life | |
| 5
years | | |
| 5
years | |
Expected volatility | |
| 121.6 | % | |
| 121.6 | % |
Expected forfeitures | |
| 0 | % | |
| 0 | % |
Expected dividends | |
| Nil | | |
| Nil | |
Revaluation date fair value per option | |
$ | 16.90 | | |
$ | 11.75 | |
| |
CAD$ | | |
$ | |
Share price at grant date | |
$ | 30.78 | | |
$ | 22.36 | |
Risk-free interest rate | |
| 3.77 | % | |
| 3.77 | % |
Expected life | |
| 5
years | | |
| 5
years | |
Expected volatility | |
| 100 | % | |
| 100 | % |
Expected forfeitures | |
| 0 | % | |
| 0 | % |
Expected dividends | |
| Nil | | |
| Nil | |
Grant date fair value per option | |
$ | 23.13 | | |
$ | 16.81 | |
| |
CAD$ | | |
$ | |
Share price at revaluation date | |
$ | 23.25 | | |
$ | 16.17 | |
Risk-free interest rate | |
| 2.47 | % | |
| 2.47 | % |
Expected life | |
| 4.3
years | | |
| 4.3
years | |
Expected volatility | |
| 121.6 | % | |
| 121.6 | % |
Expected forfeitures | |
| 0 | % | |
| 0 | % |
Expected dividends | |
| Nil | | |
| Nil | |
Revaluation date fair value per option | |
$ | 17.54 | | |
$ | 12.20 | |
| |
CAD$ | | |
$ | |
Share price at revaluation date | |
$ | 23.25 | | |
$ | 16.17 | |
Risk-free interest rate | |
| 2.47 | % | |
| 2.47 | % |
Expected life | |
| 3.7
years | | |
| 3.7
years | |
Expected volatility | |
| 121.6 | % | |
| 121.6 | % |
Expected forfeitures | |
| 0 | % | |
| 0 | % |
Expected dividends | |
| Nil | | |
| Nil | |
Revaluation date fair value per option | |
$ | 16.57 | | |
$ | 11.53 | |
| |
CAD$ | | |
$ | |
Share price at revaluation date | |
$ | 23.25 | | |
$ | 16.17 | |
Risk-free interest rate | |
| 2.47 | % | |
| 2.47 | % |
Expected life | |
| 3.1
years | | |
| 3.1
years | |
Expected volatility | |
| 121.6 | % | |
| 121.6 | % |
Expected forfeitures | |
| 0 | % | |
| 0 | % |
Expected dividends | |
| Nil | | |
| Nil | |
Revaluation date fair value per option | |
$ | 14.65 | | |
$ | 10.19 | |
|
SCHEDULE OF RESTRICTED SHARES |
A summary of the Company’s restricted shares units as at March 31, 2025, and changes for the years then ended is as follows:
SCHEDULE
OF RESTRICTED SHARES
| |
Number of RSUs | |
Balance, March 31, 2023 | |
| 18,519 | |
Issued, November 15, 2023 | |
| 5,556 | |
Balance, March 31, 2024 | |
| 24,075 | |
Issued, April 15, 2024 | |
| 1,852 | |
Issued, June 20, 2024 | |
| 37,037 | |
Issued, July 3, 2024 | |
| 359,817 | |
Issued, September 13, 2024 | |
| 74,074 | |
Issued, December 23, 2024 | |
| 296,296 | |
Cancelled | |
| (5,926 | ) |
Converted | |
| (101,852 | ) |
Balance, March 31, 2025 | |
| 685,373 | |
Exercisable, March 31, 2025 | |
| 7,639 | |
|
SCHEDULE OF RECONCILIATION SHARE BASED PAYMENTS |
A
reconciliation of share based payments is as follows:
SCHEDULE
OF RECONCILIATION SHARE BASED PAYMENTS
Share based payments | |
Stock Options | | |
RSUs | | |
Modification of broker’s warrants | | |
Settlement agreement | | |
Total | |
Previous year graded vesting | |
| 473,109 | | |
| - | | |
| - | | |
| - | | |
| 473,109 | |
New grants Q1 2023 | |
| 70,925 | | |
| - | | |
| - | | |
| - | | |
| 70,925 | |
New grants Q3 2023 | |
| 6,390,644 | | |
| 127,400 | | |
| - | | |
| - | | |
| 6,518,044 | |
Modification of broker’s warrants | |
| - | | |
| - | | |
| 440,604 | | |
| - | | |
| 440,604 | |
Revaluation RSUs | |
| - | | |
| 148,636 | | |
| - | | |
| - | | |
| 148,636 | |
Settlement agreement | |
| - | | |
| - | | |
| - | | |
| 198,801 | | |
| 198,801 | |
Balance, March 31, 2024 | |
$ | 6,934,678 | | |
$ | 276,036 | | |
$ | 440,604 | | |
$ | 198,801 | | |
$ | 7,850,119 | |
| |
| | | |
| | | |
| | | |
| | | |
| | |
Previous years graded vesting | |
| 675,250 | | |
| - | | |
| - | | |
| - | | |
| 675,250 | |
Previous years RSUs revaluation | |
| - | | |
| (231,386 | ) | |
| - | | |
| - | | |
| (231,386 | ) |
New grants Q1 2024 | |
| 128,287 | | |
| 29,948 | | |
| - | | |
| - | | |
| 158,235 | |
New grants Q2 2024 | |
| 1,542,912 | | |
| 3,049,516 | | |
| - | | |
| - | | |
| 4,592,428 | |
New grants Q3 2024 | |
| 1,291,759 | | |
| 2,621,935 | | |
| - | | |
| - | | |
| 3,913,694 | |
Cancelled options / RSUs | |
| (1,416,299 | ) | |
| (12,717 | ) | |
| - | | |
| - | | |
| (1,429,016 | ) |
Balance, March 31, 2025 | |
$ | 2,221,909 | | |
$ | 5,457,296 | | |
$ | - | | |
$ | - | | |
$ | 7,679,205 | |
|